Market Price

208.84 

1.59 0.8%

as of Mar 30 '23

52 Week Range:

41.60 260.20


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Nissan Chemical Corporation engages in the chemicals, performance materials, agricultural chemicals, and pharmaceuticals businesses in Japan and internationally. Its chemical products include MELAMINE, an adhesive agent; high purity chemicals; AdBlue, an urea solution; ammonia, sulfuric, and nitric acid; TEPIC, an epoxy compound; Melamine Cyanurate, a salt of melamine and iso cyanuric acid; Nissan Reishi, a health food; phenylphosphonic acid; HI-LITE, a chlorinated isocyanulate; OPTBEADS, a melamine-formaldehyde resin and silica; and FINEOXOCOL, a saturated fatty alcohol and acid. The company also offers performance materials comprising display, semiconductor, and inorganic materials; agricultural chemicals, such as herbicides, insecticides, fungicides, etc. for use on agricultural land, as well as in golf courses and parks; and drug substances for antiparasite drugs for animals. In addition, it provides pharmaceutical products, such as LIVALO, a cholesterol reduction agent; LANDEL and FINTE, a dual type calcium antagonist that blocks calcium channels; and custom manufacturing and process researching services for pharmaceutical ingredients. Further, the company develops healthcare, information and communication materials, and environmental and energy materials. The company was formerly known as Nissan Chemical Industries, Ltd. and changed its name to Nissan Chemical Corporation in July 2018. Nissan Chemical Corporation was founded in 1887 and is headquartered in Tokyo, Japan.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20 Mar '21 Mar '22
Equity (BVPS) 6.03
5.96
6.00
6.87
7.83
8.61
8.67
9.45
10.12
9.97
growth rate -1.2% 0.7% 14.5% 14.0% 10.0% 0.7% 9.0% 7.1% -1.5%
Earnings BIT 22,247.00
25,347.00
28,606.00
31,439.00
34,989.00
37,092.00
38,648.00
42,531.00
50,960.00
growth rate 13.9% 12.9% 9.9% 11.3% 6.0% 4.2% 10.1% 19.8%
Avg.PE 25.60
14.00
22.55
21.91
22.43
22.81
25.05
growth rate -45.3% 61.1% -2.8% 2.4% 1.7% 9.8%
ROA 5.88
7.13
8.20
8.43
9.89
10.45
11.29
11.84
12.40
13.00
growth rate 21.3% 15.0% 2.8% 17.3% 5.7% 8.0% 4.9% 4.7% 4.8%
ROE 9.55
11.37
12.74
12.71
14.65
15.14
16.13
16.55
16.90
17.49
growth rate 19.1% 12.1% -0.2% 15.3% 3.3% 6.5% 2.6% 2.1% 3.5%
ROIC 7.29
8.78
10.04
10.26
12.05
12.66
13.75
14.35
14.85
15.58
growth rate 20.4% 14.4% 2.2% 17.5% 5.1% 8.6% 4.4% 3.5% 4.9%
Cur. Ratio 2.09
2.09
2.10
2.38
2.45
2.44
2.36
2.53
2.57
2.67
growth rate 0.0% 0.5% 13.3% 2.9% -0.4% -3.3% 7.2% 1.6% 3.9%
Quick Ratio 1.50
1.51
1.47
1.65
1.70
1.72
1.68
1.80
1.80
1.84
growth rate 0.7% -2.7% 12.2% 3.0% 1.2% -2.3% 7.1% 0.0% 2.2%
Leverage 1.60
1.59
1.52
1.49
1.47
1.43
1.43
1.37
1.36
1.34
growth rate -0.6% -4.4% -2.0% -1.3% -2.7% 0.0% -4.2% -0.7% -1.5%
Balance Sheet Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20 Mar '21 Mar '22
Acct.Receivable 59,338.00
57,115.00
61,042.00
63,337.00
63,486.00
67,713.00
71,880.00
77,293.00
77,663.00
84,303.00
growth rate -3.8% 6.9% 3.8% 0.2% 6.7% 6.2% 7.5% 0.5% 8.6%
Acct.Payable 17,367.00
16,067.00
15,077.00
15,350.00
14,943.00
18,579.00
17,809.00
16,876.00
16,298.00
19,043.00
growth rate -7.5% -6.2% 1.8% -2.7% 24.3% -4.1% -5.2% -3.4% 16.8%
Cur.Assets 125,962.00
125,413.00
133,448.00
142,181.00
140,564.00
148,626.00
152,490.00
154,196.00
159,588.00
175,279.00
growth rate -0.4% 6.4% 6.5% -1.1% 5.7% 2.6% 1.1% 3.5% 9.8%
Total Assets 199,243.00
207,999.00
223,854.00
228,169.00
231,748.00
249,043.00
246,990.00
249,522.00
265,509.00
279,687.00
growth rate 4.4% 7.6% 1.9% 1.6% 7.5% -0.8% 1.0% 6.4% 5.3%
Cash 31,878.00
30,757.00
31,343.00
35,335.00
35,701.00
37,702.00
36,183.00
30,639.00
32,380.00
34,658.00
growth rate -3.5% 1.9% 12.7% 1.0% 5.6% -4.0% -15.3% 5.7% 7.0%
Inventory 30,573.00
33,179.00
36,067.00
38,507.00
36,444.00
37,767.00
41,998.00
43,874.00
46,650.00
52,175.00
growth rate 8.5% 8.7% 6.8% -5.4% 3.6% 11.2% 4.5% 6.3% 11.8%
Cur.Liabilities 60,312.00
59,652.00
56,034.00
57,937.00
57,665.00
62,871.00
60,198.00
60,015.00
59,744.00
65,971.00
growth rate -1.1% -6.1% 3.4% -0.5% 9.0% -4.3% -0.3% -0.5% 10.4%
Liabilities 72,543.00
70,179.00
72,591.00
71,246.00
68,042.00
72,679.00
64,918.00
63,996.00
64,949.00
71,679.00
growth rate -3.3% 3.4% -1.9% -4.5% 6.8% -10.7% -1.4% 1.5% 10.4%
LT Debt 8,516.00
5,450.00
9,060.00
7,100.00
4,580.00
2,446.00
1,116.00
1,076.00
1,184.00
1,182.00
growth rate -36.0% 66.2% -21.6% -35.5% -46.6% -54.4% -3.6% 10.0% -0.2%
Equity 136,551.00
149,782.00
155,392.00
162,040.00
174,586.00
180,344.00
183,916.00
198,827.00
205,911.00
growth rate 9.7% 3.8% 4.3% 7.7% 3.3% 2.0% 8.1% 3.6%
Common Shares 170.00
166.00
164.00
160.00
156.00
153.00
18,942.00
18,942.00
18,942.00
18,942.00
18,942.00
growth rate -2.4% -1.2% -2.4% -2.5% -1.9% 12,280.4% 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20 Mar '21 Mar '22
Capital Expenditures 8,039.00
8,999.00
8,568.00
9,071.00
12,394.00
13,768.00
9,747.00
8,904.00
8,254.00
11,253.00
growth rate 11.9% -4.8% 5.9% 36.6% 11.1% -29.2% -8.7% -7.3% 36.3%
Cash Dividends 4,584.00
4,814.00
6,269.00
7,680.00
9,063.00
11,320.00
12,360.00
13,629.00
15,468.00
growth rate 5.0% 30.2% 22.5% 18.0% 24.9% 9.2% 10.3% 13.5%
Cash From OA 22,839.00
23,759.00
20,452.00
29,989.00
32,491.00
37,691.00
32,070.00
35,550.00
39,939.00
41,949.00
growth rate 4.0% -13.9% 46.6% 8.3% 16.0% -14.9% 10.9% 12.4% 5.0%
FCF per Share 0.57
0.83
0.59
0.63
0.99
0.92
1.03
1.31
1.43
1.38
growth rate 45.6% -28.9% 6.8% 57.1% -7.1% 12.0% 27.2% 9.2% -3.5%
FCF 13,086.00
14,543.00
14,590.00
11,631.00
20,656.00
18,529.00
22,933.00
21,606.00
25,970.00
30,399.00
30,696.00
growth rate 11.1% 0.3% -20.3% 77.6% -10.3% 23.8% -5.8% 20.2% 17.1% 1.0%
Income Statement Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20 Mar '21 Mar '22
Sales 153,806.00
163,658.00
171,206.00
176,894.00
180,289.00
193,389.00
204,896.00
206,837.00
209,121.00
207,972.00
growth rate 6.4% 4.6% 3.3% 1.9% 7.3% 6.0% 1.0% 1.1% -0.6%
Op.Income 14,016.00
22,247.00
25,347.00
28,606.00
31,439.00
34,989.00
37,092.00
38,648.00
42,531.00
50,960.00
growth rate 58.7% 13.9% 12.9% 9.9% 11.3% 6.0% 4.2% 10.1% 19.8%
IBT 23,723.00
25,295.00
28,360.00
31,712.00
36,233.00
39,096.00
41,001.00
45,481.00
54,159.00
growth rate 6.6% 12.1% 11.8% 14.3% 7.9% 4.9% 10.9% 19.1%
Net Income 14,016.00
16,701.00
18,199.00
22,350.00
24,026.00
27,142.00
29,372.00
30,779.00
33,470.00
38,776.00
growth rate 19.2% 9.0% 22.8% 7.5% 13.0% 8.2% 4.8% 8.7% 15.9%
EPS 64.52
83.74
102.11
113.99
143.37
156.97
180.30
197.67
210.09
231.73
growth rate 29.8% 21.9% 11.6% 25.8% 9.5% 14.9% 9.6% 6.3% 10.3%
Gross Profit 55,167.00
60,381.00
65,022.00
70,748.00
74,373.00
79,876.00
84,985.00
84,458.00
87,745.00
101,089.00
growth rate 9.5% 7.7% 8.8% 5.1% 7.4% 6.4% -0.6% 3.9% 15.2%
R&D 4,196.00
4,495.00
4,445.00
4,877.00
5,112.00
5,867.00
4,492.00
4,381.00
5,052.00
growth rate 7.1% -1.1% 9.7% 4.8% 14.8% -23.4% -2.5% 15.3%

Quarterly Statements

Item Name Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Earnings BIT 11,876.00
9,448.00
12,612.00
17,024.00
17,267.00
growth rate -20.4% 33.5% 35.0% 1.4%
Balance Sheet Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Acct.Receivable 66,397.00
55,753.00
60,546.00
84,303.00
83,581.00
growth rate -16.0% 8.6% 39.2% -0.9%
Acct.Payable 15,677.00
16,019.00
19,584.00
19,043.00
18,525.00
growth rate 2.2% 22.3% -2.8% -2.7%
Cur.Assets 142,159.00
142,315.00
151,006.00
175,279.00
172,619.00
growth rate 0.1% 6.1% 16.1% -1.5%
Total Assets 246,600.00
247,426.00
254,735.00
279,687.00
277,231.00
growth rate 0.3% 3.0% 9.8% -0.9%
Cash 17,121.00
28,371.00
25,155.00
34,658.00
29,366.00
growth rate 65.7% -11.3% 37.8% -15.3%
Inventory 49,848.00
52,010.00
58,146.00
52,175.00
55,784.00
growth rate 4.3% 11.8% -10.3% 6.9%
Cur.Liabilities 47,270.00
44,403.00
49,682.00
65,971.00
61,183.00
growth rate -6.1% 11.9% 32.8% -7.3%
Liabilities 52,674.00
50,023.00
55,357.00
71,679.00
67,520.00
growth rate -5.0% 10.7% 29.5% -5.8%
LT Debt 1,184.00
963.00
963.00
1,182.00
1,182.00
growth rate -18.7% 0.0% 22.7% 0.0%
Equity 192,171.00
195,620.00
197,420.00
205,911.00
206,663.00
growth rate 1.8% 0.9% 4.3% 0.4%
Common Shares 18,942.00
18,942.00
18,942.00
18,942.00
18,942.00
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Capital Expenditures 2,812.00
2,440.00
977.00
5,024.00
3,449.00
growth rate -13.2% -60.0% 414.2% -31.4%
Cash Dividends 8,341.00
7,127.00
7,127.00
10,208.00
10,208.00
growth rate -14.6% 0.0% 43.2% 0.0%
Cash From OA 11,849.00
21,916.00
1,243.00
6,941.00
13,107.00
growth rate 85.0% -94.3% 458.4% 88.8%
FCF 9,037.00
19,476.00
266.00
1,917.00
9,658.00
growth rate 115.5% -98.6% 620.7% 403.8%
Income Statement Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Sales 46,499.00
45,308.00
49,530.00
66,635.00
58,290.00
growth rate -2.6% 9.3% 34.5% -12.5%
Op.Income 11,876.00
9,448.00
12,612.00
17,024.00
17,267.00
growth rate -20.4% 33.5% 35.0% 1.4%
IBT 12,322.00
9,964.00
13,718.00
18,155.00
19,491.00
growth rate -19.1% 37.7% 32.3% 7.4%
Net Income 8,849.00
7,442.00
9,349.00
13,136.00
13,869.00
growth rate -15.9% 25.6% 40.5% 5.6%
Gross Profit 23,828.00
21,704.00
24,910.00
30,647.00
30,264.00
growth rate -8.9% 14.8% 23.0% -1.3%
R&D 5,052.00
5,052.00
5,052.00
5,052.00
growth rate 0.0% 0.0% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (59.37)

YOY Growth Grade:

C (54.58)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 27.14 125.96
EPS / Growth 1.66

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 4.7%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 4.7% 4.7% 4.7%
Future PE 0.01 4.73 4.73
Future EPS 2.63 2.63 2.63
Value Price
MOS %
0.01
-100.0%
3.07
-98.5%
3.07
-98.5%
MOS Price 0.00 1.54 1.54
IRT 41.17 41.17 41.17

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.